Garlic: Empiricism or science?

Natural Product Communications

Volumn 4, Issue 12, 2009, Pages 1785-1796

  Aviello, Gabriella ^a   Abenavoli, Ludovico ^b   Borrelli, Francesca ^a   Capasso, Raffaele ^a   Izzo, Angelo Antonio ^a   Lembo, Francesca ^a   Romano, Barbara ^a   Capasso, Francesco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Alliaceae; Allium sativum; Cancer; Garlic; Hypercholesterolemia; Hypertension

Indexed keywords

AJOENE; ALLICIN; ALLIIN; ALLIOSON; ALPRAZOLAM; ASCORBIC ACID; CHLORZOXAZONE; CHOLESTEROL; DEBRISOQUINE; DEXTROMETHORPHAN; FLUINDIONE; FRUCTOSE OLIGOSACCHARIDE; GARLIC EXTRACT; KAEMPFEROL; KNEIPP; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIDAZOLAM; PARACETAMOL; PLACEBO; RETINOL; RITONAVIR; SAQUINAVIR; SELENIUM; SULFUR; UNCLASSIFIED DRUG; VALVARDE; WARFARIN; ANTILIPEMIC AGENT; CARDIOTONIC AGENT;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBACTERIAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIOSCLEROSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; BLOATING; BLOOD CLOTTING TIME; BLOOD PRESSURE MEASUREMENT; BREAST CANCER; BURN; CANDIDIASIS; CARCINOGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CLINICAL TRIAL; COLON CANCER; COMMON COLD; CYSTITIS; DIABETES MELLITUS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; ENDOMETRIUM CANCER; EPIGASTRIC PAIN; ESOPHAGUS CANCER; ESOPHAGUS PAIN; FEVER; FIBRINOLYSIS; FLATULENCE; GARLIC; GASTROINTESTINAL SYMPTOM; HALITOSIS; HEART DISEASE; HEART INFARCTION; HEART PROTECTION; HEMATEMESIS; HEMATOCHEZIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; INFECTION; INTERMITTENT CLAUDICATION; KIDNEY CARCINOMA; LARYNX CANCER; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; LUNG CANCER; MENIERE DISEASE; MICTURITION; MOUTH CANCER; MOUTH ULCER; NAURU; NONHUMAN; OVARY CANCER; PHOTOALLERGY; POSTOPERATIVE HEMORRHAGE; PREECLAMPSIA; PROSTATE CANCER; RETROBULBAR HEMORRHAGE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN ALLERGY; SKIN ODOR; SMALL INTESTINE OBSTRUCTION; SPINAL HEMATOMA; STOMACH CANCER; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; URTICARIA; VASCULAR RESISTANCE; VOMITING; WOUND; ANIMAL; BOTANY; CHEMISTRY; CLASSIFICATION; DRUG INTERACTION; HISTORY; NEOPLASM; PHYTOTHERAPY;

ALLIACEAE; ALLIUM SATIVUM; HEXAPODA;

ANIMALS; ANTILIPEMIC AGENTS; ATHEROSCLEROSIS; BOTANY; CARDIOTONIC AGENTS; DRUG INTERACTIONS; GARLIC; HISTORY, 17TH CENTURY; HUMANS; NEOPLASMS; PHYTOTHERAPY;

EID: 77649267891     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0900401231     Document Type: Review

References (112)

1. Rivlin RS. (2001) Historical perspective on the use of garlic. Journal of Nutrition, 131, 9515-9545.
2. Banerjee SK, Maulik SK. (2002) Effect of garlic on cardiovascular disorder: a review. Journal of Nutrition, 136, 1-14.
3. Rahman K, Lowe GM. (2006) Garlic and cardiovascular disease: a critical review. Journal of Nutrition, 136, 736S-740S.
4. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. (2001) Intake of garlic and its bioactive components. Journal of Nutrition, 131, 9555-9625.
5. Nagini S. (2008) Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise? Anticancer Agents in Medicinal Chemistry, 8, 313-321.
6. Seki T, Hosono T, Hosono-Fukao T, Inada K, Tanaka R, Ogihara J, Ariga T. (2008) Anticancer effects of diallyl trisulfide derived from garlic. Asia Pacific Journal of Clinical Nutrition, 17, 249-252.
7. Münchberg U, Anwar A, Mecklenburg S, Jacob C. (2007) Polysulfides as biologically active ingredients of garlic. Organic & Biomolecular Chemistry, 5, 1505-1518.
8. Block E. (1985) The chemistry of garlic and onions. Scientific American, 252, 114-119.
9. Lawson LD, Wang ZJ. (2005) Allicin and allicin-derived garlic compounds increase breath acetone through allyl methyl sulfide: use in measuring allicin bioavailability. Journal of Agriculture and Food Chemistry, 53, 1974-1983.
10. Koch HP, Hahn G, Lawson L, Reuter HD, Siegers CP. (1996) Garlic. The science and the therapeutic applications of Allium sativum L. and related species. 2nd Ed, Williams and Wilkins.
11. Jandkle J, Spiteller G. (1987) Unusual conjugates in biological profiles originating from consumption of onions and garlic. Journal of Chromatography, 421, 1-8.
12. Mennella JA, Beauchamp GK. (1991) Maternal diet alters the sensory qualities of human milk and the nursling's behaviour. Pediatrics, 88, 737-744.
13. Banerjea SK, Mukherjee PK, Mauli KSK. (2003) Garlic as an antioxidant: the good, the bad and the ugly. Phytotherapy Research, 17, 97-106.
14. Rahman K. (2007) Effects of garlic on platelet biochemistry and physiology. Molecular Nutrition & Food Research, 51, 1335-1344.
15. Devrim E, Durak I. (2007) Is garlic a promising food for benign prostatic hyperplasia and prostate cancer? Molecular Nutrition & Food Research, 51, 1319-1323.
16. Milner JA. (1996) Garlic: its anticarcinogenic and antitumorigenic properties. Nutrition Reviews, 54, 582-586.
17. Adetumbi M, Lau BHS. (1983) Allium sativum (garlic) a natural antibiotic. Medical Hypotheses, 12, 227-237.
18. Fulder S. (1989) Garlic and the prevention of cardiovascular disease. Cardiology Practice, 7, 30-35.
19. Borek C. (2001) Antioxidant health effects of aged garlic extract. Journal of Nutrition, 131, 51010-51015.
20. Yhe Y-Y, Liu L. (2001) Cholesterol-lowering effect of garlic extract and organosulfur compounds: human and animal studies. Journal of Nutrition, 131, 5989-5993.
21. Le Bon A-M, Siness M-H. (2001) Organosulfur compounds from Allium and the chemoprevention of cancer. Drug Metabolism and Drug Interaction, 17, 51-79.
22. Qureshi AA, Abiurmeileh N, Din ZZ, Elson CE, Burger WC. (1983) Inhibition of cholesterol and fatty acid biosynthesis in liver enzymes and chicken hepatocytes by polar fractions of garlic. Lipids, 18, 343-348.
23. Gebhardt R. (1993) Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids, 28, 613-619.
24. Gebhardt R. (1995) Amplification of palmitate-induced inhibition of cholesterol biosynthesis in cultured rat hepatocytes by garlicderived organosulfur compounds. Phytomedicine, 2, 29-34.
25. Gupta N, Porter TD. (2001) Garlic and garlic-derived compounds inhibit human squalene monooxygenase. Journal of Nutrition, 131, 1662-1667. (Pubitemid 32520429)
26. Singh DK, Porter TD. (2006) Inhibition of sterol 4á-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. Journal of Nutrition, 136, 759S-764S.
27. Sheela CG, Augusti KT. (1995) Effects of S-allyl cysteine sulfoxide isolated from Allium sativum Linn and gugulipid on some enzymes and faecal excretions of bile acids and sterols in cholesterol fed rats. Indian Journal of Experimental Biology, 33, 749-751.
28. Liu L, Yhe Y-Y. (2001) Water-soluble organosulfur compounds of garlic inhibit fatty acid and triglyceride synthesis in cultured rat hepatocytes. Lipids, 36, 395-400.
29. Campbell JH, Efendy JL, Smith NJ, Campbell GR. (2001) Molecular basis by which garlic suppresses atherosclerosis. Journal of Nutrition, 131, 1006-1009.
30. Abramowitz D. (1999) Allicin-induced decrease in formation of fatty steaks (atherosclerosis) in mice fed a cholesterol-rich diet. Coronary Artery Disease, 10, 515-519.
31. Gorinstein S, Jastrzebski Z, Namiesnik J, Leontowicz H, Leontowicz M, Trakhtenberg S. (2007) The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Molecular Nutrition & Food Research, 51, 1365-1381.
32. Chandorkar AG, Jain PK. (1973) Analysis of hypertensive action of Allium sativum (garlic). Indian Journal of Physiology and Pharmacology, 17, 132-133.
33. Malik ZA, Siddiqui S. (1981) Hypotensive effect of freeze-dried garlic (Allium sativum) SAP in dog. Journal of the Pakistan Medical Association, 31, 12-13.
34. Al-Qattan KK, Alnaqeeb MA, Ali M. (1999) The antihypertensive effect of garlic (Allium sativum) in the rat two-kidney-one-clip Goldblatt model. Journal of Ethnopharmacology, 66, 217-222.
35. Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RM, Mustafa T. (2000) Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins, Leukotrienes & Essential Fatty Acids, 62, 253-259.
36. Jacob R, Rhrsam M, Ohkubo T, Rupp H. (1991) Antihypertensive and kardioprotektive effekt von knoblauchpulver (Allium sativum). Medizinische Welt, 7, 39-41.
37. Siegel G, Emden J, Wenzel K, Mironneau J, Stock G. (1992) Potassium channel activation in vascular smooth muscle. In: Frank GB. (Ed.). Excitation-contracting coupling in skeletal, cardiac and smooth muscle. Plenum Press, New York.
38. Das I, Khan NS, Sooranna SR. (1995) Potent activation of nitric oxide synthase by garlic: a base for its therapeutic applications. Current Medical Research and Opinion, 13, 257-263.
39. Kim-Park S, Ku DD. (2000) Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clinical and Experimental Pharmacology and Physiology, 27, 780-786.
40. Boullin DJ. (1981) Garlic as a platelet inhibitor. Lancet, 1, 776-777.
41. Gaffen JD, Tavares IA, Bennett A. (1984) The effect of garlic extracts on contractions of rat gastric fundus and human platelet aggregation. Journal of Pharmacy and Pharmacology, 36, 272-274.
42. Srivastava KC. (1986) Evidence for the mechanism by which garlic inhibits platelet aggregation. Prostaglandins,Leukotrienes and Medicine, 22, 313-321.
43. Apitz-Castro R, Cabrera S, Cruz MR, Ledezma E, Jain MK. (1983) Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thrombosis Research, 32, 155-169. (Pubitemid 14238545)
44. Wagner H, Wierer M, Fessler B. (1987) Effects of garlic constituents on arachidonate metabolism. Planta Medica, 53, 305-306.
45. Sharma CP, Nirmala NV. (1985) Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure--comments. Thrombosis Research, 37, 489-490.
46. Ciplea AG, Richter KD. (1988) The protective effect of Allium sativum and Crataegus on isoprenaline-induced tissue necrosis in rats. Arzneimittel- Forschung, 38, 1583-1592.
47. Isansee H, Riatz B, Jacob R. (1993) Cardioprotective actions of garlic (Allium sativum). Arzneimittel-Forschung, 43, 94-98.
48. Siegers CP, Röbke A, Pentz R. (1999) Effects of garlic preparations on superoxide production by phorbol ester activated granulocytes. Phytomedicine, 6, 13-16. (Pubitemid 129632488)
49. Kourounakis PN, Rekka EA. (1991) Effect of active oxygen species of alliin and Allium sativum (garlic) powder. Research Communications in Chemical Pathology & Pharmacology, 74, 249-252.
50. Ide N, Lau BH. (1997) Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. Journal of Pharmacy and Pharmacology, 49, 908-911. (Pubitemid 27424871)
51. nd communication: Inhibition of the Cu(2+)-initiated oxidation of low density lipoproteins. Arzneimittel-Forschung, 44, 604-607.
52. Popov I, Blumstein A, Lewin G. (1994) Antioxidant effects of aqueous garlic extract. 1st communication: Direct detection using the photochemiluminescence. Arzneimittel-Forschung, 44, 602-604.
53. Török B, Belágyi J, Rietz B, Jacob R. (1994) Effectiveness of garlic on the radical activity in radical generating systems. Arzneimittel-Forschung, 44, 608-611.
54. Herman-Antosiewicz A, Powolny AA, Singh SV. (2007) Molecular targets of cancer chemoprevention by garlic-derived organosulfides. Acta Pharmacologica Sinica, 28, 1355-1364.
55. El-Bayoumy K, Sinha R, Pinto JT, Rivlin RS. (2006) Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. Journal of Nutrition, 136, 864S-869S.
56. Milner JA. (2006) Preclinical perspectives on garlic and cancer. Journal of Nutrition, 136, 827S-831S.
57. Khanum F, Anilakumar KR, Viswanathan KR. (2004) Anticarcinogenic properties of garlic: a review. Critical Reviews in Food Science and Nutrition, 44, 479-488.
58. Pinto JT, Lapsia S, Shah A, Santiago H, Kim G. (2001) Antiproliferative effects of garlic-derived and other Allium related compounds. Advances in Experimental Medicine and Biology, 492, 83-106. (Pubitemid 32682069)
59. Bianchini F, Vainio H. (2001) Allium vegetables and organosulfur compounds: do they help prevent cancer? Environmental Health Perspectives, 109, 893-902.
60. Sharma VD, Sethi MS, Kumar A, Rarotra JR. (1977) Antibacterial property of Allium sativum Linn.: in vivo & in vitro studies. Indian Journal of Experimental Biology, 15, 466-468. (Pubitemid 8182781)
61. Kumar M, Berwal JS. (1998) Sensitivity of food pathogens to garlic (Allium sativum). Journal of Applied Microbiology, 84, 213-215. (Pubitemid 28137008)
62. Davis LE, Shen J, Royer RE. (1994) In vitro synergism of concentrated Allium sativum extract and amphotericin B against Cryptococcus neoformans. Planta Medica, 60, 546-549.
63. Ross ZM, O'Gara EA, Hill DJ, Sleightholme HV, Maslin DJ. (2001) Antimicrobial properties of garlic oil against human enteric bacteria: evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder. Applied and Environmental Microbiology, 67, 475-480.
64. Shashikanth KN, Basappa SC, Sreenivasa Murthy V. (1984) A comparative study of raw garlic extract and tetracycline on caecal microflora and serum proteins of albino rats. Folia Microbiologica, 29, 348-352.
65. Lamm DL, Riggs DR. (2000) The potential application of Allium sativum (garlic) for the treatment of bladder cancer. Urologic Clinics of North America, 27, 157-162. (Pubitemid 30086007)
66. Lau BH, Yamasaki T, Gridley DS. (1991) Garlic compounds modulate macrophage and T-lymphocyte functions. Molecular Biotherapy, 3, 103-107.
67. Reuter HD, Sendl A. (1994) Alium sativum and Allium ursinum: Chemistry, Pharmacology and Medicinal Applications. In Wagner H. (Ed.), Economic and medicinal plant research, 6. Academic Press, London, 55-113.
68. Liu C-T, Sheen L-Y, Lii C-K. (2007) Does garlic have a role as an antidiabetic agent? Molecular Nutrition & Food Research, 51, 1353-1364.
69. Stevinson C, Pittler MH, Ernst E. (2000) Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Annals of Internal Medicine, 133, 420-429.
70. Ernst E, Pittler MH, Wider B, Boddy K. (2008) The Oxford Handbook of Complementary Medicine, Oxford University Press, Oxford.
71. Khoo YSK, Aziz Z. (2009) Garlic supplementation and serum cholesterol: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics, 34, 133-145.
72. Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM. (2008) Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Annals of Pharmacotherapy, 42, 1766-1771.
73. Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. (2008) Effect of garlic on blood pressure: a systematic review and metaanalysis. BMC Cardiovascular Disorders, 8, 13-24.
74. Meher S, Duley L. (2006) Garlic for preventing pre-eclampsia and its complications. Cochrane Database Systematic Reviews, 3, CD006065.
75. Koscielny J, Klussendorf D, Latza R, Schmitt R, Radtke H, Siegel G, Kiesewetter H. (1999) The antiatherosclerotic effect of Allium sativum. Atherosclerosis, 144, 237-249.
76. Breithaupt-Grogler K, Ling M, Boudoulas H, Belz GG. (1997) Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation, 96, 2649-2655. (Pubitemid 27451358)
77. Budoff M. (2006) Aged garlic extract retards progression of coronary artery calcification. Journal of Nutrition, 136, 741S-744S.
78. Herman-Antosiewicz A, Singh SV. (2004) Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutation Research, 555, 121-131.
79. Milner JA. (2001) Mechanisms by which garlic and allyl sulphur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Advances in Experimental Medicine and Biology, 492, 69-81.
80. Sheen LY, Chen HW, Kung YL, Liu CT and Lii CK. (1999) Effects of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and antioxidant enzymes in rats fed high- and low-fat diets. Nutrition and Cancer, 35, 160-166.
81. Germain E, Chevalier J, Siess MH, Teyssier C. (2003) Hepatic metabolism of diallyl disulphide in rat and man. Xenobiotica 33, 1185-1199.
82. Chen C, Pung D, Leong V, Hebbar V, Shen G, Nair S, Li W and Kong AN. (2004) Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radical Biology and Medicine, 37, 1578-1590.
83. Gong P, Hu B, Cederbaum AI. (2004) Diallyl sulphide induces heme oxygenase-1 through MAPK pathway. Archives of Biochemistry and Biophysics, 432, 252-260.
84. Kim JY, Kwon O. (2009) Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. American Journal of Clinical Nutrition, 89, 257-264.
85. Ngo SNI, Williams DB, Cobiac L, Head RJ. (2007) Does garlic reduced risk of colorectal cancer? A systematic review. Journal of Nutrition, 137, 2264-2269.
86. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. (2001) Garlic shows promise for improving some cardiovascular risk factors. Archives of Internal Medicine, 161, 813-824. (Pubitemid 32225389)
87. Pittler MH, Ernst E. (2007) Clinical effectiveness of garlic (Allium sativum). Molecular Nutrition & Food Research, 51, 1382-1385.
88. Izzo AA. (2007) Efficacy and safety of Allium sativum (garlic). Focus on Alternative and Complementary Therapies, 12, 162-166.
89. Alvarez MS, Jacobs S, Jiang SB, Brancaccio RR, Soter NA, Cohen DE. (2003) Photocontact allergy to diallyl disulfide. American Journal of Contact Dermatitis, 14, 161-165.
90. Borrelli F, Capasso R, Izzo AA. (2007) Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Molecular Nutrition & Food Research, 51, 1386-1397.
91. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS. (Eds). (1998) The complete German Commission E monographs: therapeutic guide to herbal medicines. American Botanical Council, Austin, TX.
92. Hoshino T, Kashimoto N, Kasuga S. (2001) Effects of garlic preparations on the gastrointestinal mucosa. Journal of Nutrition, 131, 1109S-1113S.
93. Beck E, Grunwald J. (1993) Allium sativum in der Stufentherapie der Hyperlipidaemie. Medizinische Welt, 44, 516-520.
94. Papageorgiou C, Corbet JP, Menezes-Brandao F, Pecegueiro M, Benezra C. (1983) Allergic contact dermatitis to garlic (Allium sativum L.). Identification of the allergens: the role of mono-, di-, and trisulfides present in garlic. A comparative study in man and animal (guinea-pig). Archives of Dermatology Research, 275, 229-234.
95. Kao SH, Hsu CH, Su SN, Hor WT, Chang T WH, Chow LP. (2004) Identification and immunologic characterization of an allergen, alliin lyase, from garlic (Allium sativum). Journal of Allergy Clinical Immunology, 113, 161-188.
96. Bagge S, Thomas BS, Bhat M. (2008) Garlic burn as self-inflicted mucosal injury- a case report and review of the literature. Quintessence International, 39, 491-494.
97. Bojs G, Svensson A. (1988) Contact allergy to garlic used for wound healing. Contact Dermatitis, 18, 179-181. (Pubitemid 18077555)
98. Burden AD, Wilkinson SM, Beck MH, Chalmers RJ. (1994) Garlic-induced systemic contact dermatitis. Contact Dermatitis, 30, 299-300.
99. Pires G, Pargana E, Loureiro V, Almeida MM, Pinto JR. (2002) Allergy to garlic. Allergy, 57, 957-958.
100. Asero R, Mistrello G, Roncarolo D, Antoniotti PL, Falagiani P. (1998) A case of garlic allergy. Journal of Allergy and Clinical Immunology, 101, 427-428.
101. Sanchez-Hernandez MC, Hernandez M, Delgado J, Guardia P, Monteseirin J, Bartolomé B, Palacios R, Martinez J, Conde J. (2000) Allergenic cross-reactivity in the Liliaceae family. Allergy, 55, 297-299.
102. Brenner S. (1999) Pemphigus and diet. Have we solved the mystery of fogo selvagem? Advances in Experimental Medicine and Biology, 455, 267-269.
103. Ruocco V, Brenner S, Lombardi ML. (1996) A case of diet-related pemphigus. Dermatology, 192, 373-374.
104. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY. (2005) Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging, 22, 525-539.
105. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY. (2002) Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clinical Pharmacology & Therapeutics, 72, 276-287.
106. Macan H, Uykimpang R, Alconcel M, Takasu J, Razon R, Amagase H, Niihara Y. (2006) Aged garlic extract may be safe for patients on warfarin therapy. Journal of Nutrition, 136, 793S-795S.
107. Mohammed Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, McLachlan AJ. (2008) Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. British Journal of Pharmacology, 154, 1691-1700.
108. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. (2002) The effect of garlic supplements on the pharmacokinetics of saquinavir. Clinical Infectious Diseases, 34, 234-238.
109. Gallicano K, Foster B, Choudhri S. (2003) Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. British Journal of Clinical Pharmacology, 55, 199-202.
110. Laroche M, Choudhuri S, Gallicano K, Foster B. (1998) Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. The Canadian Journal of Infectious Diseases, 9, 471.
111. Barnes J, Anderson LA, Phillipson JD. (2002) Herbal Medicine, 2nd Ed., Pharmaceutical Press, London.
112. Capasso F, Gaginella TS, Grandolini G, Izzo AA. (2003) Phytotherapy. A Quick Reference to Herbal Medicine, Springer-Verlag, Berlin, Heidelberg.